1. Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy
- Author
-
Stephen J. Gadomski, Byron W.H. Mui, Raphael Gorodetsky, Sriram S. Paravastu, Joseph Featherall, Li Li, Abigail Haffey, Jae-Chun Kim, Sergei A. Kuznetsov, Kathryn Futrega, Astar Lazmi-Hailu, Randall K. Merling, Daniel Martin, Andrew W. McCaskie, and Pamela G. Robey
- Subjects
cell biology ,molecular biology ,Physiology ,stem cells research ,Science - Abstract
Summary: Stem cell therapies for degenerative cartilage disease are limited by an incomplete understanding of hyaline cartilage formation and maintenance. Human bone marrow stromal cells/skeletal stem cells (hBMSCs/SSCs) produce stable hyaline cartilage when attached to hyaluronic acid-coated fibrin microbeads (HyA-FMBs), yet the mechanism remains unclear. In vitro, hBMSC/SSC/HyA-FMB organoids exhibited reduced BMP signaling early in chondrogenic differentiation, followed by restoration of BMP signaling in chondrogenic IGFBP5+/MGP+ cells. Subsequently, human-induced pluripotent stem cell (hiPSC)-derived sclerotome cells were established (BMP inhibition) and then treated with transforming growth factor β (TGF-β) −/+ BMP2 and growth differentiation factor 5 (GDF5) (BMP signaling activation). TGF-β alone elicited a weak chondrogenic response, but TGF-β/BMP2/GDF5 led to delamination of SOX9+ aggregates (chondrospheroids) with high expression of COL2A1, ACAN, and PRG4 and minimal expression of COL10A1 and ALP in vitro. While transplanted hBMSCs/SSCs/HyA-FMBs did not heal articular cartilage defects in immunocompromised rodents, chondrospheroid-derived cells/HyA-FMBs formed non-hypertrophic cartilage that persisted until at least 5 months in vivo.
- Published
- 2024
- Full Text
- View/download PDF